Clinical studies recruiting near Perth

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Linear Clinical Research · Pfizer · NCT05020236 Precision Medicine for Every Child With Cancer
Phase N/A · Perth Children's Hospital · Australian & New Zealand Children's Haematology/Oncology Gro · NCT05504772 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Sir Charles Gairdner Hospital · Eli Lilly and Company · NCT07218380 The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Phase 1/Phase 2 · Q Medical Conselling · Lin BioScience, Inc · NCT05756322 Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
NA · Saluda Medical Pty Ltd · NCT04662905 A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · Perth Children's Hospital · University of Birmingham · NCT05991388 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · Perth Children's Hospital · Princess Maxima Center for Pediatric Oncology · NCT05327894 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · Perth Children's Hospital · National Cancer Institute (NCI) · NCT05099003 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Sir Charles Gairdner Hospital · Pfizer · NCT06758401 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Perth Children's Hospital · National Cancer Institute (NCI) · NCT06172296 IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Phase 1 · Linear Clinical Research · Iksuda Therapeutics Ltd. · NCT05365659 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · PedAL BCU, LLC · NCT05183035 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Perth Children's Hospital · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Perth Children's Hospital · National Cancer Institute (NCI) · NCT05691478 TLN-372 in Advanced KRAS Mutant Solid Tumors
Phase 1 · Linear Clinical Research · Treeline Biosciences, Inc. · NCT07204340 A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · Hemab ApS · NCT06754852 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Sir Charles Gairdner Hospital · Eli Lilly and Company · NCT06890598 Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · Children's Hospital of Philadelphia · NCT02708134 Combination Therapy for the Treatment of Diffuse Midline Gliomas
Phase 2 · University of California, San Francisco · NCT05009992 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Perth Children's Hospital · Eli Lilly and Company · NCT07222332 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Perth Children's Hospital · Children's Oncology Group · NCT04322318 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · The Perth Blood Institute · Loxo Oncology, Inc. · NCT05254743 ROADMAP Clinical Trial
Phase 4 · Royal Perth Hospital · University of Newcastle, Australia · NCT06771050 First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-S
EARLY_Phase 1 · Icon Cancer Centre Hollywood · Integrated Haematology and Oncology Network · NCT07608848 A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Neurodegenerative Disorders Research · Bristol-Myers Squibb · NCT06976216 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · SAb Biotherapeutics, Inc. · NCT07187531 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Fiona Stanley Hospital ( Site 1803) · Merck Sharp & Dohme LLC · NCT06833073 Laryngoscopy for Neonatal and Infant Airway Management wIth Supplemental Oxygen at Different Flow Rates (OPTIMISE-2)
NA · Perth Children's Hospital · Thomas Riva · NCT05967507 High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris · NCT04221035

Look up another city

Look up another condition